Vascular imaging devices market seen reaching $11.12 billion by 2030

The vascular imaging devices market is projected to grow from $8.89 billion in 2026 to $11.12 billion by 2030, driven by rising cardiovascular disease, more early-detection use cases and wider adoption of non-invasive imaging tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The vascular imaging devices market is expanding as healthcare systems face more diabetes, hypertension and other cardiovascular risks that require earlier diagnosis and ongoing monitoring. - Growth in non-invasive and portable imaging tools could broaden access to vascular screening beyond major hospitals. - The market outlook points to more spending on imaging infrastructure, digital health integration and AI-assisted analysis.

What happened: - The Business Research Company projected the vascular imaging devices market will rise from $8.89 billion in 2026 to $11.12 billion by 2030. - The forecast implies a 5.8% compound annual growth rate over the period. - The market was valued at $8.4 billion in 2025. - North America was the largest regional market in 2025. - Asia-Pacific is expected to post the fastest growth through the forecast period.

The details: - Vascular imaging devices use non-invasive imaging methods to visualize blood vessels and the circulatory system. - The devices support diagnosis and management of cardiovascular conditions and help clinicians monitor treatment progress. - Growth in the market has been supported by rising cardiovascular disease rates, improved diagnostic imaging infrastructure, wider use of ultrasound and angiography systems, more imaging services in hospitals and a larger supply of skilled radiology professionals. - Future demand is expected to be supported by early disease detection, investment in advanced imaging technologies, growth in outpatient diagnostic centers, tighter integration with digital health platforms and better portable devices. - Key trends expected ahead include greater use of AI-based image analysis, stronger demand for non-invasive methods, more high-resolution imaging, wider use of minimally invasive diagnostics and a sharper focus on early cardiovascular diagnosis. - The report covered Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition added market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The report offered a free sample at Download a free sample. - The full market report is available at View the full report.

Between the lines: - The market outlook reflects a broader shift toward earlier cardiovascular detection, where imaging becomes a first-line tool instead of only a follow-up test. - The emphasis on outpatient centers and portable devices suggests more care may move outside traditional hospital settings. - The WHO said in September 2025 that about 1.4 billion adults ages 30 to 79 were living with hypertension in 2024, and only 23% had blood pressure under control. - That gap helps explain why demand for vascular imaging may keep rising even in mature healthcare markets.

What's next: - The strongest growth opportunities are likely to come from Asia-Pacific as healthcare access expands and imaging adoption increases. - Vendors may continue to compete on AI, portability, resolution and workflow integration rather than on hardware alone. - The market will likely benefit if more providers use imaging for routine early screening of cardiovascular disease risk.

The bottom line: - Vascular imaging devices are moving from a niche diagnostic category toward a broader cardiovascular care tool, with steady global growth expected through 2030.